The company's clinical chemistry test uses the NGAL biomarker to determine a patient's risk of acute kidney injury.

Proscia has integrated its Concentriq platform with AWS HealthImaging to provide a cloud-native foundation for pathology.

The submitted test runs on the firm's point-of-care instrument and detects four respiratory pathogens within 10 minutes directly from patient nasal swab samples.

The program is intended to advance the development of antigen tests that can be used in homes and at the point-of-care to aid the detection of dangerous infections.

Under the agreement, Tempus and Renalytix will work with US healthcare systems to make the KidneyintelX.dkd test more available to order within existing clinical workflows.

Last week, readers were most interested in a story about a possible sale of Siemens Healthineer's IVD business, leading to an uptick in the company's share price.

The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.

Compared to the firm's previous PGx offering, the new service is somewhat smaller in terms of content and better supported by ...

NEW YORK – The US Food and Drug Administration in August granted 510(k) marketing clearances for various antimicrobial susceptibility tests, several respiratory disease tests, and a cardiac troponin ...